Wellesley, MA, United States of America

Martin Freed

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Parkinson’s Disease Treatment: The Contributions of Martin Freed

Introduction

Martin Freed is an innovative inventor based in Wellesley, MA, known for his significant contributions to healthcare, particularly in the field of neurology. He has developed a unique method aimed at improving treatment for Parkinson's disease, an affliction that affects millions worldwide.

Latest Patents

Freed holds one patent titled "Methods for reducing inter-patient variability of levodopa plasma concentrations." This invention addresses the challenges faced by Parkinson's disease patients regarding variability in levodopa plasma concentrations, which can affect treatment efficacy. The patent involves a novel pulmonary administration of levodopa, designed to create therapeutically effective concentrations, especially beneficial during the critical window of 10 to 60 minutes post-inhalation. This innovative approach is particularly useful in managing the motor fluctuations that can arise as side effects of traditional L-Dopa therapy.

Career Highlights

Currently, Martin Freed is associated with Civitas Therapeutics, Inc., where his research focused on developing groundbreaking therapies for neurological disorders. His dedication to innovating treatment options has not only showcased his ingenuity but also his commitment to improving patient care and quality of life for those suffering from Parkinson's disease.

Collaborations

Throughout his career, Freed collaborates with notable professionals, including Richard P. Batycky. These partnerships foster innovative ideas and drive research efforts toward transforming treatments in neurology.

Conclusion

In summary, Martin Freed stands as an exemplary inventor whose work is making significant strides in the treatment of Parkinson's disease. His innovative patent addresses critical challenges in the administration of levodopa, which can lead to improved outcomes for patients. With ongoing collaborations and a commitment to his research, Freed continues to contribute meaningfully to the field of medicine and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…